Hum. Reprod. Advance Access originally published online on December 22, 2005
Human Reproduction 2006 21(4):905-908; doi:10.1093/humrep/dei437
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles
Center for Reproductive Medicine, Department of Obstetrics and Gynaecology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
1 To whom correspondence should be addressed at: Center for Reproductive Medicine, Department of Obstetrics and Gynaecology, Academic Medical Center, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands. E-mail: m.h.mochtar{at}amc.uva.nl
BACKGROUND: The aim of this study was to compare the effect of three different times of onset of luteal phase support on ongoing pregnancy rate in infertile patients undergoing treatment with GnRH down-regulated IVF and embryo transfer (IVF/ET). MATERIALS AND METHODS: All consecutive eligible patients planned to undergo their first IVF treatment cycle were randomly allocated to receive vaginal progesterone as luteal support at three different time points, that is, after HCG administration for final oocyte maturation (HCG group), at the day of oocyte retrieval (OR group) or at the day of ET (ET group). The primary endpoint of this study was ongoing pregnancy rate. RESULTS: A total of 385 women were randomized, 130 were allocated to the HCG group, 128 to the OR group and 127 to the ET group. An ongoing pregnancy rate of 20.8% was found in the HCG group versus 22.7 and 23.6% in the OR group and ET group, respectively. The mean number and quality of the retrieved oocytes and the transferred embryos did not differ. CONCLUSION: Based on this data, an 18% difference in ongoing pregnancy rate between the three different times of onset of luteal phase support in GnRH agonist down-regulated IVF/ET cycles can be refuted. Smaller clinically meaningful differences may be present.
Key words: controlled ovarian hyperstimulation/GnRH agonist/IVF/luteal phase support/randomized trial
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. A. Aboulghar, Y. M. Amin, H. G. Al-Inany, M. M. Aboulghar, L. M. Mourad, G. I. Serour, and R. T. Mansour Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks Hum. Reprod., April 1, 2008; 23(4): 857 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.M. Fatemi, B. Popovic-Todorovic, E. Papanikolaou, P. Donoso, and P. Devroey An update of luteal phase support in stimulated IVF cycles Hum. Reprod. Update, November 1, 2007; 13(6): 581 - 590. [Abstract] [Full Text] [PDF] |
||||

